Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 3,073 | 2,165 | 1,964 | 0 | 0 |
| Gross Profit | 3,073 | 2,165 | 1,964 | N/A | N/A |
| Operating Expenses | 16,731 | 16,137 | 15,163 | 12,111 | 11,557 |
| Operating Income | -13,658 | -13,972 | -13,199 | -12,111 | -11,557 |
| Interest Expense | 119 | 127 | 131 | 129 | 110 |
| Other Income | 1,423 | 1,275 | 539 | 1,095 | 266 |
| Pre-tax Income | -12,354 | -12,824 | -12,791 | -11,145 | -11,401 |
| Net Income Continuous | -12,354 | -12,824 | -12,791 | -11,145 | -11,401 |
| Net Income | $-12,354 | $-12,824 | $-12,791 | $-11,145 | $-11,401 |
| EPS Basic Total Ops | -22.56 | -24.06 | -30.08 | -35.34 | -36.09 |
| EPS Basic Continuous Ops | -22.82 | -23.78 | -30.15 | -35.56 | -36.38 |
| EPS Diluted Total Ops | -22.56 | -24.06 | -30.08 | -35.34 | -36.09 |
| EPS Diluted Continuous Ops | -22.82 | -23.78 | -30.15 | -35.56 | -36.38 |
| EBITDA(a) | $-13,779 | $-14,203 | $-13,363 | $-12,180 | $-11,533 |